Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2018 16:01 ET | Source: CareDx, Inc.

CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA

BRISBANE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 26, 2018 16:01 ET | Source: CareDx, Inc.

CareDx Strengthens Executive Leadership Team with the Appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer

BRISBANE, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 26, 2018 08:00 ET | Source: CareDx, Inc.

CareDx Announces Full Repayment of its Outstanding Debt

BRISBANE, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 16, 2018 16:01 ET | Source: CareDx, Inc.

CareDx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

BRISBANE, Calif., Nov. 16, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 13, 2018 23:19 ET | Source: CareDx, Inc.

CareDx Announces Pricing of Public Offering of Common Stock

BRISBANE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 13, 2018 16:01 ET | Source: CareDx, Inc.

CareDx Announces Proposed Public Offering of Common Stock

BRISBANE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
November 08, 2018 16:01 ET | Source: CareDx, Inc.

CareDx Reports Third Quarter Results

AlloSure launch momentum drives 74% revenue growth BRISBANE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company focused on the discovery,...
November 07, 2018 08:00 ET | Source: CareDx, Inc.

CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
October 17, 2018 08:00 ET | Source: CareDx, Inc.

CareDx to Announce Third Quarter 2018 Financial Results on November 8, 2018

BRISBANE, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
October 02, 2018 08:00 ET | Source: CareDx, Inc.

CareDx Profiles AlloSeq Suite of NGS Products at ASHI

Expands portfolio with three new kitted transplant products launching in 2019 Delivers new insights into the clinical Transplantome by incorporating HLA plus additional genes contributing to...